| pubmed-article:19335742 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19335742 | lifeskim:mentions | umls-concept:C0000956 | lld:lifeskim |
| pubmed-article:19335742 | lifeskim:mentions | umls-concept:C0152171 | lld:lifeskim |
| pubmed-article:19335742 | lifeskim:mentions | umls-concept:C1704675 | lld:lifeskim |
| pubmed-article:19335742 | lifeskim:mentions | umls-concept:C1704271 | lld:lifeskim |
| pubmed-article:19335742 | pubmed:dateCreated | 2009-4-1 | lld:pubmed |
| pubmed-article:19335742 | pubmed:abstractText | Sitaxentan inhibits the metabolism of warfarin, resulting in a need for adjustment of warfarin dose when both drugs are coadministered. We report the long-term effects on bleeding of acenocoumarol co-administered as part of conventional therapy for pulmonary hypertension with sitaxentan in a subset of patients enrolled in the Sitaxentan To Relieve ImpaireD Exercise-3 (STRIDE-3) study. | lld:pubmed |
| pubmed-article:19335742 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19335742 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19335742 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19335742 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19335742 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19335742 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19335742 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19335742 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19335742 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19335742 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19335742 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19335742 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19335742 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:19335742 | pubmed:issn | 1365-2362 | lld:pubmed |
| pubmed-article:19335742 | pubmed:author | pubmed-author:SandovalJJ | lld:pubmed |
| pubmed-article:19335742 | pubmed:author | pubmed-author:LupuII | lld:pubmed |
| pubmed-article:19335742 | pubmed:author | pubmed-author:SantosEE | lld:pubmed |
| pubmed-article:19335742 | pubmed:author | pubmed-author:GutiérrezRR | lld:pubmed |
| pubmed-article:19335742 | pubmed:author | pubmed-author:RoquesVV | lld:pubmed |
| pubmed-article:19335742 | pubmed:author | pubmed-author:MirandaM TMT | lld:pubmed |
| pubmed-article:19335742 | pubmed:author | pubmed-author:RuedaTT | lld:pubmed |
| pubmed-article:19335742 | pubmed:author | pubmed-author:PeñaHH | lld:pubmed |
| pubmed-article:19335742 | pubmed:author | pubmed-author:PulidoTT | lld:pubmed |
| pubmed-article:19335742 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19335742 | pubmed:volume | 39 Suppl 2 | lld:pubmed |
| pubmed-article:19335742 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19335742 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19335742 | pubmed:pagination | 14-8 | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:meshHeading | pubmed-meshheading:19335742... | lld:pubmed |
| pubmed-article:19335742 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19335742 | pubmed:articleTitle | Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension. | lld:pubmed |
| pubmed-article:19335742 | pubmed:affiliation | Cardiopulmonary Department, National Heart Institute, Mexico City, Mexico. tpulido@prodigy.net.mx | lld:pubmed |
| pubmed-article:19335742 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19335742 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:19335742 | pubmed:publicationType | Multicenter Study | lld:pubmed |
